Vnitr Lek 2023, 69(3):166-172 | DOI: 10.36290/vnl.2023.029

Critical care for multimorbid patients

Marcela Královcová1, Thomas Karvunidis1, 2, Martin Matějovič1, 2
1 Jednotka intenzivní péče, I. interní klinika, Lékařská fakulta v Plzni, Univerzita Karlova a Fakultní nemocnice Plzeň
2 Biomedicínské centrum, Lékařská fakulta v Plzni, Univerzita Karlova

Multimorbidity - the simultaneous presence of several chronic diseases - is very common in the critically ill patients. Its prevalence is roughly 40-85 % and continues to increase further. Certain chronic diseases such as diabetes, obesity, chronic heart, pulmonary, liver or kidney disease and malignancy are associated with higher risk of developing serious acute complications and therefore the possible need for intensive care. This review summarizes and discusses selected specifics of critical care for multimorbid patients.

Keywords: multimorbidity, chronic disease, intensive care, organ dysfunction.

Accepted: April 27, 2023; Published: May 16, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Královcová M, Karvunidis T, Matějovič M. Critical care for multimorbid patients. Vnitr Lek. 2023;69(3):166-172. doi: 10.36290/vnl.2023.029.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Simpson A, Puxty K, McLoone P, et al. Comorbidity and survival after admission to the intensive care unit: A population‑based study of 41,230 patients. J Intensive Care Soc. 2021;22(2):143-51. Go to original source... Go to PubMed...
    2. Beil M, Flaatten H, Guidet B, et al. The management of multi‑morbidity in elderly patients: Ready yet for precision medicine in intensive care? Crit Care. 2021;25(1):330. Go to original source... Go to PubMed...
    3. Skou ST, Mair FS, Fortin M, et al. Multimorbidity. Nat Rev Dis Prim. 2022;8(1):48. Go to original source... Go to PubMed...
    4. Nguyen H, Manolova G, Daskalopoulou C, et al. Prevalence of multimorbidity in community settings: A systematic review and meta‑analysis of observational studies. J comorbidity. 2019;9:2235042X19870934. Go to original source...
    5. Danai PA, Moss M, Mannino DM, et al. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432-40. Go to original source... Go to PubMed...
    6. Hodgin KE, Moss M. The epidemiology of sepsis. Curr Pharm Des. 2008;14(19):1833-9. Go to original source...
    7. Shappell C, Rhee C, Klompas M. Update on Sepsis Epidemiology in the Era of COVID-19. Semin Respir Crit Care Med. 2023;44(1):173-84. Go to original source... Go to PubMed...
    8. Miller PE, Thomas A, Breen TJ, et al. Prevalence of Noncardiac Multimorbidity in Patients Admitted to Two Cardiac Intensive Care Units and Their Association with Mortality. Am J Med. 2021;134(5):653-661.e5. Go to original source... Go to PubMed...
    9. The Academy of Medical Sciences. Multi‑morbidity: a priority for global health research. 2018. https://acmedsci.ac.uk/fledownload/82222 577.
    10. Min H, Avramovic S, Wojtusiak J, et al. A Comprehensive Multimorbidity Index for Predicting Mortality in Intensive Care Unit Patients. J Palliat Med. 2017;20(1):35-41. Go to original source... Go to PubMed...
    11. Guidet B, de Lange DW, Boumendil A, et al. The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study. Intensive Care Med. 2020;46(1):57-69. Go to original source... Go to PubMed...
    12. Nielsen AB, Thorsen‑Meyer H‑C, Belling K, et al. Survival prediction in intensive‑care units based on aggregation of long‑term disease history and acute physiology: a retrospective study of the Danish National Patient Registry and electronic patient records. Lancet Digit Heal. 2019;1(2):e78-89.
    13. Paratz J, Thomas P, Adsett J. Re‑admission to intensive care: identification of risk factors. Physiother Res Int J Res Clin Phys Ther. 2005;10(3):154-63. Go to original source... Go to PubMed...
    14. Ho KM, Dobb GJ, Lee KY, et al. The effect of comorbidities on risk of intensive care readmission during the same hospitalization: a linked data cohort study. J Crit Care. 2009;24(1):101-7. Go to original source...
    15. Clerencia‑Sierra M, Calderón‑Larrañaga A, Martínez‑Velilla N, et al. Multimorbidity Patterns in Hospitalized Older Patients: Associations among Chronic Diseases and Geriatric Syndromes. PLoS One. 2015;10(7):e0132909. Go to original source... Go to PubMed...
    16. Damluji AA, Forman DE, van Diepen S, et al. Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association. Circulation. 2020;141(2):e6-32. Go to original source... Go to PubMed...
    17. St Sauver JL, Boyd CM, Grossardt BR, et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. 2015;5(2):e006413. Go to original source... Go to PubMed...
    18. Pepper DJ, Demirkale CY, Sun J, et al. Does Obesity Protect Against Death in Sepsis? A Retrospective Cohort Study of 55,038 Adult Patients. Crit Care Med. 2019;47(5):643-50. Go to original source... Go to PubMed...
    19. Karvunidis T, Lysak D, Matejovic M. Dospely onkologicky nemocny v intenzivni peci. Je jiz cas rici "ano, zvazime to" nez rikat "ne"?! Anesteziol a Intenziv Med [Internet]. 2017;28(6):346-53.
    20. Forman DE, Maurer MS, Boyd C, et al. Multimorbidity in Older Adults With Cardiovascular Disease. J Am Coll Cardiol. 2018;71(19):2149-61. Go to original source...
    21. Kivelitz L, Schäfer J, Kanat M, et al. Patient‑Centeredness in Older Adults With Multimorbidity: Results of an Online Expert Delphi Study. Gerontologist. 2021;61(7):1008-18. Go to original source... Go to PubMed...
    22. McNelly AS, Flower L, Stephens TJ, et al. Attitudes of multimorbid patients to surviving future acute illness and subsequent functional disability: A systematic review. medRxiv [Internet]. 2020;1.
    23. Wald R, Beaubien‑Souligny W, et al. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Intensive Care Med. 2022;48(10):1368-81. Go to original source... Go to PubMed...
    24. Boyer N, Horne K, Selby NM, et al. Renal medicine in the intensive care unit: a narrative review. Anaesthesia. 2023; 11; doi:10.1111/anae.15964. Go to original source... Go to PubMed...
    25. Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019;38(1):48-79. Go to original source... Go to PubMed...
    26. Compher C, Bingham AL, McCall M, et al. Guidelines for the provision of nutrition support therapy in the adult critically ill patient: The American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2022;46(1):12-41. Go to original source... Go to PubMed...
    27. Joshi N, Caputo GM, Weitekamp MR, et al. Infections in patients with diabetes mellitus. N Engl J Med. 1999;341(25):1906-12. Go to original source... Go to PubMed...
    28. Graham BB, Keniston A, Gajic O, et al. Diabetes mellitus does not adversely affect outcomes from a critical illness. Crit Care Med. 2010;38(1):16-24. Go to original source... Go to PubMed...
    29. Stegenga ME, Vincent J‑L, Vail GM, et al. Diabetes does not alter mortality or hemostatic and inflammatory responses in patients with severe sepsis. Crit Care Med. 2010;38(2):539-45. Go to original source... Go to PubMed...
    30. Vincent J‑L, Preiser J‑C, Sprung CL, et al. Insulin‑treated diabetes is not associated with increased mortality in critically ill patients. Crit Care. 2010;14(1):R12. Go to original source... Go to PubMed...
    31. Michalia M, Kompoti M, Koutsikou A, et al. Diabetes mellitus is an independent risk factor for ICU‑acquired bloodstream infections. Intensive Care Med. 2009;35(3):448-54. Go to original source... Go to PubMed...
    32. Freire AX, Bridges L, Umpierrez GE, et al. Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest. 2005;128(5):3109-16. Go to original source... Go to PubMed...
    33. Whitcomb BW, Pradhan EK, Pittas AG, et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Crit Care Med. 2005;33(12):2772-7. Go to original source... Go to PubMed...
    34. Esper AM, Moss M, Martin GS. The effect of diabetes mellitus on organ dysfunction with sepsis: an epidemiological study. Crit Care. 2009;13(1):R18. Go to original source... Go to PubMed...
    35. Ali NA, O'Brien JMJ, Dungan K, et al. Glucose variability and mortality in patients with sepsis. Crit Care Med. 2008;36(8):2316-21. Go to original source... Go to PubMed...
    36. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol. 2009;3(6):1292-301. Go to original source... Go to PubMed...
    37. Hermanides J, Vriesendorp TM, Bosman RJ, et al. Glucose variability is associated with intensive care unit mortality. Crit Care Med. 2010;38(3):838-42. Go to original source... Go to PubMed...
    38. Boord JB, Graber AL, Christman JW, et al. Practical management of diabetes in critically ill patients. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1763-7. Go to original source... Go to PubMed...
    39. Anderson MR, Shashaty MG. Impact of Obesity in Critical Illness. Chest. 2021;160(6):2135-45.Další literatura u autora a na www.casopisvnitrnilekarstvi.cz Go to original source... Go to PubMed...
    40. Zhao Y, Li Z, Yang T, et al. Is body mass index associated with outcomes of mechanically ventilated adult patients in intensive critical units? A systematic review and meta‑analysis. PLoS One. 2018;13(6):e0198669. Go to original source... Go to PubMed...
    41. Pepper DJ, Sun J, Welsh J, et al. Increased body mass index and adjusted mortality in ICU patients with sepsis or septic shock: a systematic review and meta‑analysis. Crit Care. 2016;20(1):181. Go to original source... Go to PubMed...
    42. Karampela I, Chrysanthopoulou E, Christodoulatos GS, et al. Is There an Obesity Paradox in Critical Illness? Epidemiologic and Metabolic Considerations. Curr Obes Rep. 2020;9(3):231-44. Go to original source... Go to PubMed...
    43. El Solh A. (ed). Critical Care Management of the Obese Patient. John Wiley & Sons 2012; ISBN 978-0-470-65590-0. Go to original source...
    44. Schetz M, De Jong A, Deane AM, et al. Obesity in the critically ill: a narrative review. Intensive Care Med [Internet]. 2019;45(6):757-69. Go to original source... Go to PubMed...
    45. Dixon BJ, Dixon JB, Carden JR, et al. Preoxygenation is more effective in the 25 degrees head‑up position than in the supine position in severely obese patients: a randomized controlled study. Anesthesiology. 2005;102(6):1110-5. Go to original source... Go to PubMed...
    46. Guérin C, Reignier J, Richard J‑C, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159-68. Go to original source... Go to PubMed...
    47. Galvagno SMJ, Pelekhaty S, Cornachione CR, et al. Does Weight Matter? Outcomes in Adult Patients on Venovenous Extracorporeal Membrane Oxygenation When Stratified by Obesity Class. Anesth Analg. 2020;131(3):754-61. Go to original source... Go to PubMed...
    48. O'Brien JMJ, Philips GS, Ali NA, et al. The association between body mass index, processes of care, and outcomes from mechanical ventilation: a prospective cohort study. Crit Care Med. 2012;40(5):1456-63. Go to original source... Go to PubMed...
    49. Dennis BM, Eckert MJ, Gunter OL, et al. Safety of bedside percutaneous tracheostomy in the critically ill: evaluation of more than 3,000 procedures. J Am Coll Surg. 2013;216(4):857-8. Go to original source... Go to PubMed...
    50. Ouellette DR, Patel S, Girard TD, et al. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline: Inspiratory Pressure Augmentation During Spontaneous Breathing Trials, Protocols Mini. Chest. 2017;151(1):166-80. Go to original source... Go to PubMed...
    51. Stéphan F, Bérard L, Rézaiguia‑Delclaux S, et al. High‑Flow Nasal Cannula Therapy Versus Intermittent Noninvasive Ventilation in Obese Subjects After Cardiothoracic Surgery. Respir Care. 2017;62(9):1193-202. Go to original source... Go to PubMed...
    52. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347(5):305-13. Go to original source...
    53. Vyas V, Lambiase P. Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities. Arrhythmia Electrophysiol Rev. 2019;8(1):28-36. Go to original source...
    54. Ejerblad E, Fored CM, Lindblad P, et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol. 2006;17(6):1695-702. Go to original source... Go to PubMed...
    55. Soto GJ, Frank AJ, Christiani DC, et al. Body mass index and acute kidney injury in the acute respiratory distress syndrome. Crit Care Med. 2012;40(9):2601-8. Go to original source... Go to PubMed...
    56. Vasquez CR, DiSanto T, Reilly JP, et al. Relationship of body mass index, serum creatine kinase, and acute kidney injury after severe trauma. J Trauma Acute Care Surg. 2020;89(1):179-85. Go to original source... Go to PubMed...
    57. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204. Go to original source... Go to PubMed...
    58. Gaudry S, Palevsky PM, Dreyfuss D. Extracorporeal Kidney‑Replacement Therapy for Acute Kidney Injury. N Engl J Med. 2022;386(10):964-75. Go to original source... Go to PubMed...
    59. Dossett LA, Dageforde LA, Swenson BR, et al. Obesity and site‑specific nosocomial infection risk in the intensive care unit. Surg Infect (Larchmt). 2009;10(2):137-42. Go to original source...
    60. Bochicchio G V, Joshi M, Bochicchio K, et al. Impact of obesity in the critically ill trauma patient: a prospective study. J Am Coll Surg. 2006;203(4):533-8. Go to original source... Go to PubMed...
    61. Roe JL, Fuentes JM, Mullins ME. Underdosing of common antibiotics for obese patients in the ED. Am J Emerg Med. 2012;30(7):1212-4. Go to original source... Go to PubMed...
    62. Erstad BL, Barletta JF. Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis. Crit Care. 2021;25(1):77. Go to original source... Go to PubMed...
    63. Puurunen MK, Gona PN, Larson MG, et al. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res. 2016;145:27-33. Go to original source... Go to PubMed...
    64. Rosito GA, D'Agostino RB, Massaro J, et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost. 2004;91(4):683-9. Go to original source... Go to PubMed...
    65. Willenberg T, Schumacher A, Amann‑Vesti B, et al. Impact of obesity on venous hemodynamics of the lower limbs. J Vasc Surg. 2010;52(3):664-8. Go to original source... Go to PubMed...
    66. Sebaaly J, Covert K. Enoxaparin Dosing at Extremes of Weight: Literature Review and Dosing Recommendations. Ann Pharmacother. 2018;52(9):898-909. Go to original source... Go to PubMed...
    67. Cascio V, Hon M, Haramati LB, et al. Imaging of suspected pulmonary embolism and deep venous thrombosis in obese patients. Br J Radiol. 2018;91(1089):20170956. Go to original source... Go to PubMed...
    68. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014;129(3):e28-292.
    69. Christiansen MN, Køber L, Weeke P, et al. Age‑Specific Trends in Incidence, Mortality, and Comorbidities of Heart Failure in Denmark, 1995 to 2012. Circulation. 2017;135(13):1214-23. Go to original source...
    70. Walker AMN, Drozd M, Hall M, et al. Prevalence and Predictors of Sepsis Death in Patients With Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction. J Am Heart Assoc. 2018;7(20):e009684. Go to original source... Go to PubMed...
    71. Metkus TS, Lindsley J, Fair L, et al. Quality of Heart Failure Care in the Intensive Care Unit. J Card Fail. 2021;27(10):1111-25. Go to original source... Go to PubMed...
    72. Cook DJ, Webb S, Proudfoot A. Assessment and management of cardiovascular disease in the intensive care unit. Heart. 2022;108(5):397-405. Go to original source... Go to PubMed...
    73. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet (London, England). 2007;370(9589):765-73. Go to original source... Go to PubMed...
    74. Almirall J, Bolíbar I, Balanzó X, et al. Risk factors for community‑acquired pneumonia in adults: a population‑based case‑control study. Eur Respir J. 1999;13(2):349-55. Go to original source... Go to PubMed...
    75. Torres A, Dorca J, Zalacaín R, et al. Community‑acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med. 1996;154(5):1456-61. Go to original source... Go to PubMed...
    76. Love ME, Proud D. Respiratory Viral and Bacterial Exacerbations of COPD‑The Role of the Airway Epithelium. Cells. 2022;11(9).
    77. Nseir S, Di Pompeo C, Cavestri B, et al. Multiple‑drug‑resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome. Crit Care Med. 2006;34(12):2959-66. Go to original source... Go to PubMed...
    78. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community‑acquired pneumonia. Eur Respir J. 2006;27(6):1210-6. Go to original source... Go to PubMed...
    79. Hess Dr. Evidence‑Based Respiratory Care. Respir Care. 2021;66(7):1105-19. Go to original source... Go to PubMed...
    80. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038-47. Go to original source... Go to PubMed...
    81. Rocha E, Soares M, Valente C, et al. Outcomes of critically ill patients with acute kidney injury and end‑stage renal disease requiring renal replacement therapy: a case‑control study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2009;24(6):1925-30.
    82. Strijack B, Mojica J, Sood M, et al. Outcomes of chronic dialysis patients admitted to the intensive care unit. J Am Soc Nephrol. 2009;20(11):2441-7. Go to original source... Go to PubMed...
    83. Hotchkiss JR, Palevsky PM. Care of the critically ill patient with advanced chronic kidney disease or end‑stage renal disease. Curr Opin Crit Care. 2012;18(6):599-606. Go to original source... Go to PubMed...
    84. Pesanti EL. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am. 2001;15(3):813-32. Go to original source... Go to PubMed...
    85. Cruz DN, Goh CY, Marenzi G, Corradi V, Ronco C, Perazella MA. Renal replacement therapies for prevention of radiocontrast‑induced nephropathy: a systematic review. Am J Med. 2012;125(1):66-78.e3. Go to original source...
    86. Weisbord SD, Palevsky PM. Iodinated contrast media and the role of renal replacement therapy. Adv Chronic Kidney, DiS. 2011;18(3):199-206. Go to original source... Go to PubMed...
    87. Karvellas CJ, Pink F, McPhail M, et al. Bacteremia, acute physiology and chronic health evaluation II and modified end stage liver disease are independent predictors of mortality in critically ill nontransplanted patients with acute on chronic liver failure. Crit Care Med. 2010;38(1):121-6. Go to original source... Go to PubMed...
    88. Das V, Boelle P‑Y, Galbois A, et al. Cirrhotic patients in the medical intensive care unit: early prognosis and long‑term survival. Crit Care Med. 2010;38(11):2108-16. Go to original source...
    89. Karvellas CJ, Bagshaw SM. Advances in management and prognostication in critically ill cirrhotic patients. Curr Opin Crit Care. 2014;20(2):210-7. Go to original source... Go to PubMed...
    90. Lin C‑Y, Tsai I‑F, Ho Y‑P, et al. Endotoxemia contributes to the immune paralysis in patients with cirrhosis. J Hepatol. 2007;46(5):816-26. Go to original source... Go to PubMed...
    91. Berry PA, Antoniades CG, Carey I, et al. Severity of the compensatory anti‑inflammatory response determined by monocyte HLA‑DR expression may assist outcome prediction in cirrhosis. Intensive Care Med. 2011;37(3):453-60. Go to original source... Go to PubMed...
    92. Arabi YM, Dara SI, Memish Z, et al. Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis. Hepatology. 2012;56(6):2305-15. Go to original source... Go to PubMed...
    93. Bajaj JS, O'Leary JG, Reddy KR, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end‑stage liver disease (NACSELD) experience. Hepatology. 2012;56(6):2328-35. Go to original source... Go to PubMed...
    94. Carbonell N, Pauwels A, Serfaty L, et al. Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology. 2004;40(3):652-9. Go to original source... Go to PubMed...
    95. Garcia‑Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single‑topic conference. Hepatology. 2008;47(5):1764-72. Go to original source... Go to PubMed...
    96. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2010;53(4):762-8. Go to original source... Go to PubMed...
    97. Levacher S, Letoumelin P, Pateron D, et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet (London, England). 1995;346(8979):865-8. Go to original source... Go to PubMed...
    98. García‑Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010;362(25):2370-9. Go to original source... Go to PubMed...
    99. Wong F, O'Leary JG, Reddy KR, et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology. 2013;145(6):1280-8. Go to original source... Go to PubMed...
    100. Sanyal AJ, Boyer T, Garcia‑Tsao G, et al. A randomized, prospective, double‑blind, placebo‑controlled trial of terlipressin for type 1 hepatorenal syndrome. Gastroenterology. 2008;134(5):1360-8. Go to original source... Go to PubMed...
    101. Martín‑Llahí M, Pépin M‑N, Guevara M, et al. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. Gastroenterology. 2008;134(5):1352-9. Go to original source...
    102. Sharma P, Kumar A, Shrama BC, et al. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response. Am J Gastroenterol. 2008;103(7):1689-97. Go to original source...
    103. Kinsey T, Jemal A, Liff J, et al. Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001. J Natl Cancer Inst. 2008;100(14):1003-12. Go to original source... Go to PubMed...
    104. Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population‑based registries in 71 countries. Lancet. 2018;391(10125):1023-75. Go to original source... Go to PubMed...
    105. Puxty K, McLoone P, Quasim T, et al. Risk of Critical Illness Among Patients With Solid Cancers: A Population‑Based Observational Study. JAMA Oncol. 2015;1(8):1078-85. Go to original source... Go to PubMed...
    106. Schellongowski P, Staudinger T, Kundi M, et al. Prognostic factors for intensive care unit admission, intensive care outcome, and post‑intensive care survival in patients with de novo acute myeloid leukemia: a single center experience. Haematologica. 2011;96(2):231-7. Go to original source... Go to PubMed...
    107. Azoulay E, Schellongowski P, Darmon M, et al. The Intensive Care Medicine research agenda on critically ill oncology and hematology patients. Intensive Care Med. 2017;43(9):1366-82. Go to original source... Go to PubMed...
    108. Tanvetyanon T, Leighton JC. Life‑sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic cancer. Crit Care Med. 2003;31(1):60-4. Go to original source... Go to PubMed...
    109. Staudinger T, Stoiser B, Müllner M, et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med. 2000;28(5):1322-8. Go to original source... Go to PubMed...
    110. Massion PB, Dive AM, Doyen C, et al. Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med. 2002;30(10):2260-70. Go to original source... Go to PubMed...
    111. Song J‑U, Suh GY, Park HY, et al. Early intervention on the outcomes in critically ill cancer patients admitted to intensive care units. Intensive Care Med. 2012;38(9):1505-13. Go to original source... Go to PubMed...
    112. Mokart D, Lambert J, Schnell D, et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma. 2013;54(8):1724-9. Go to original source... Go to PubMed...
    113. Schellongowski P, Sperr WR, Wohlfarth P, et al. Critically ill patients with cancer: chances and limitations of intensive care medicine‑a narrative review. ESMO open. 2016;1(5):e000018. Go to original source... Go to PubMed...
    114. Darmon M, Thiery G, Ciroldi M, et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med. 2005;33(11):2488-93. Go to original source... Go to PubMed...
    115. Benoit DD, Depuydt PO, Vandewoude KH, et al. Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit. Intensive Care Med. 2006;32(1):93-9. Go to original source...
    116. Vandijck DM, Benoit DD, Depuydt PO, et al. Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies. Intensive Care Med. 2008;34(5):847-55. Go to original source...
    117. Karvunidis T, Matějovič M. Oncologic emergencies. Vnitr Lek. 2019;65(6):405-15. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.